Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 19,513,858 |
|
|||||
| News | - | ||||||
| Day High | 0.2056 | Low High |
|||||
| Day Low | 0.15 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.06704 | -29.82% | 0.15776 | 16:59:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.2055 | 0.15 | 0.2056 | 0.15776 | 0.2248 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,388 | 19,513,858 | $ 0.167378 | $ 3,266,187 | - | 0.1275 - 0.418 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:08:24 | formt | 13,151 | $ 0.17 | USD |
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 156.72M | 921.12M | 556.02M | 0 | -79.82M | -0.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.24 | 0.315 | 0.15 | 0.2602397 | 5,593,333 | -0.08224 | -34.27% |
| 1 Month | 0.14 | 0.315 | 0.1366 | 0.2289645 | 2,277,515 | 0.01776 | 12.69% |
| 3 Months | 0.188 | 0.315 | 0.1275 | 0.1909213 | 1,672,438 | -0.03024 | -16.09% |
| 6 Months | 0.1655 | 0.418 | 0.1275 | 0.2012442 | 2,774,068 | -0.00774 | -4.68% |
| 1 Year | 0.275 | 0.418 | 0.1275 | 0.2038706 | 2,085,340 | -0.11724 | -42.63% |
| 3 Years | 1.93 | 2.54 | 0.1275 | 0.5974136 | 2,154,924 | -1.77 | -91.83% |
| 5 Years | 0.398 | 10.01 | 0.1275 | 2.15 | 2,901,098 | -0.24024 | -60.36% |
CytoDyn (QB) Description
| CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |
